Evidence map›Paper›PMID 33614236›Full record

ArticleMolecular therapy. Nucleic acids2021

Circular RNA RBPMS inhibits bladder cancer progression via miR-330-3p/RAI2 regulation.

Chen Yang, Zezhong Mou, Zheyu Zhang, Siqi Wu, Quan Zhou, Yiling Chen, Jian Gong, Chenyang Xu, Yuxi Ou, Xinan Chen and 2 more

Open access · goldAbstract read
In one paragraph

Article in Molecular therapy. Nucleic acids, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
3.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 40 citations in OpenAlex.

  1. Review
  2. Circular RNAs and Cancers.Advances in experimental medicine and biology · 2025
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Exosome-derived circTRPS1 promotes malignant phenotype and CD8+ T cell exhaustion in bladder cancer microenvironments.Molecular therapy : the journal of the American Society of Gene Therapy · 2022
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Chen YangDepartment of Urology, Huashan Hospital, Fudan University, Shanghai 200040, China.
Zezhong MouDepartment of Urology, Huashan Hospital, Fudan University, Shanghai 200040, China.
Zheyu ZhangDepartment of Urology, Huashan Hospital, Fudan University, Shanghai 200040, China.
Siqi WuDepartment of Urology, Huashan Hospital, Fudan University, Shanghai 200040, China.
Quan ZhouDepartment of Urology, Huashan Hospital, Fudan University, Shanghai 200040, China.
Yiling ChenDepartment of Urology, Huashan Hospital, Fudan University, Shanghai 200040, China.
Jian GongFudan Institute of Urology, Huashan Hospital, Fudan University, Shanghai 200040, China.
Chenyang XuDepartment of Urology, Huashan Hospital, Fudan University, Shanghai 200040, China.
Yuxi OuDepartment of Urology, Huashan Hospital, Fudan University, Shanghai 200040, China.
Xinan ChenDepartment of Urology, Huashan Hospital, Fudan University, Shanghai 200040, China.
Xiyu DaiDepartment of Urology, Huashan Hospital, Fudan University, Shanghai 200040, China.
Haowen JiangDepartment of Urology, Huashan Hospital, Fudan University, Shanghai 200040, China.
Fudan University · CNHuashan Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bladder cancer is a severe cancer with high mortality because of invasion and metastasis. Growing evidence has revealed that circular RNAs play critical roles in biological function, which is closely connected to proliferation and invasion of bladder cancer. In our study, we employed qRT-PCR, RNA fluorescence

Indexed as

bladder cancercircRBPMSEMTERKmiR-330-3pRAI2

Identifiers

PMID33614236
PMCPMC7868720
OpenAlexW3122587807

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.